TissueScan, Cancer Survey cDNA Array 384 - I

SKU
CSRT502
TissueScan Cancer Survey Panel 384 - I containing ten identical sets of 381 tissues covering twenty two (22) different cancers
  $6,240.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Survey
Array Name Cancer Survey cDNA Array 384 - I
Clinical Info
Diagnosis Category Multiple
Tissue Multiple
Shipping Ambient
Description TissueScan Cancer Survey Panel 384 - I containing ten identical sets of 381 tissues covering twenty two (22) different cancers
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers
Abou-Fadel, Qu, Gonzalez et al
Oncol. Rep. (2020) 43 (6), 1945-1963 DOI: 10.3892/or.2020.7550
Cited by 34
AI Summary: OriGene's TissueScan™ Real-Time PCR panels (HMRT100, 103, CSRT502) and Human β-actin control primer set were used to assess the endogenous expression levels of CCM2 isoforms across different tissues at the transcriptional level in this study.
Snippet: TissueScan Real-Time PCR panels (HMRT100, 103, CSRT502) with Human β-actin control primer set (Origene) were used to determine the endogenous expression levels of CCM2 isoforms among the different tissues at the transcriptional level;- TissueScan Real-Time PCR panels (HMRT100, 103, CSRT502) with Human β-actin control primer set (Origene) were used to determine the endogenous expression levels of CCM2 isoforms among the different tissues at the transcriptional level;- TissueScan Real‑Time PCR panels (HMRT100, 103, CSRT502) with Human β‑actin control primer set (Origene) were used to determine the endogenous expression levels of CCM2 isoforms among the different tissues at the transcrip‑ tional level
Alternatively spliced isoforms reveal a novel type of PTB domain in CCM2 protein
Jiang, Padarti, Qu et al
Sci Rep (2019) 9 (1), 15808 DOI: 10.1038/s41598-019-52386-0
AI Summary: OriGene’s TissueScan™ Real-Time PCR panels (HMRT100, 103, CSRT502) and Human ß-actin control primer set were used to quantify the RNA levels of CCM2 isoforms across various human tissues in this study.
Snippet: Allele-specific real-time quantitative PCR (qPCR) assays were designed using boundary-spanning primer sets (Suppl. … TissueScan Real-Time PCR panels (HMRT100, 103, CSRT502) with Human ß-actin control primer set (Origene, MD)
FigureFigureFigure
Novel functions of CCM1 delimit the relationship of PTB/PH domains
Zhang, Dubey, Padarti et al
Biochim. Biophys. Acta (2017) 1865 (10), 1274-1286 DOI: 10.1016/j.bbapap.2017.07.002
AI Summary: OriGene's TissueScan™ Real-Time PCR panels (HMRT100, 103, CSRT502) and human β-actin control primers were used to measure CCM1 expression levels across various human tissues in this study.
Snippet: TissueScan Real-Time PCR panels (HMRT100, 103, CSRT502) and human β-actin control primers (Origene) were used to determine the relative expression levels of CCM1 in multiple human tissues
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products